CD4 and thyroid gland carcinoma: The discovery of the cell surface receptor for thyroid hormone analogues on the extracellular domain of integrin αvβ3 that is overexpressed by cancer cells and active endothelial cells raised the possibility that thyroid hormones as T4 might be, like TSH, a circulating growth factor for solid tumors, including thyroid cancers.